• ACSL1 Drives Ferroptosis Resistance in Ovarian Cancer Sphero

  2026-05-28

  This study uncovers how ACSL1 promotes platinum resistance in ovarian cancer by enhancing FSP1 N-myristoylation, resulting in increased ferroptosis resistance. The findings clarify a novel lipid metabolism–driven mechanism underlying antioxidant capacity and cell death regulation in the context of cancer therapy.

• Ferrostatin-1 (Fer-1): Applied Workflows in Ferroptosis Assa

  2026-05-27

  Ferrostatin-1 (Fer-1) empowers researchers to selectively inhibit ferroptosis with high sensitivity and reproducibility in cancer biology and neurodegenerative disease models. This guide delivers actionable experimental workflows, troubleshooting insights, and evidence-based protocol enhancements to accelerate translational research using APExBIO’s trusted compound.

• PHF2 Histone Demethylase Regulates Neuroinflammation in Alzh

  2026-05-27

  This study identifies PHF2 as a central epigenetic regulator of inflammatory gene expression in Alzheimer’s disease (AD). By demonstrating that PHF2 knockdown reduces neuroinflammation and improves cognitive function in a mouse model, the research highlights PHF2 as a promising therapeutic target for AD and other neuroinflammatory disorders.

• Tofacitinib Citrate (CP-690550): Precision in JAK3 Research

  2026-05-26

  Tofacitinib citrate (CP-690550 citrate) offers unmatched selectivity for JAK3, enabling nuanced dissection of immune signaling and endothelial inflammation. This guide presents optimized workflows, protocol parameters, and troubleshooting insights for researchers leveraging this compound in immune regulation and inflammatory disease models.

• Shufeng Xingbi Therapy Modulates Immunity and Microbiota in

  2026-05-26

  This study demonstrates that Shufeng Xingbi Therapy (SFXBT) restores Th1/Th2 immune balance and beneficially alters intestinal flora in a rat model of allergic rhinitis (AR). The findings highlight SFXBT’s capacity to alleviate nasal inflammation by regulating immune signaling and microbiome composition, offering mechanistic insights relevant to translational immunology.

• DGLA-Induced Ferroptosis via ACSL4 in Acute Myeloid Leukemia

  2026-05-25

  This study uncovers how exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight new mechanistic links between fatty acid metabolism and ferroptotic cell death, suggesting novel therapeutic strategies for treatment-resistant AML.

• Angiotensin 1/2 (1-6): Redefining RAS Research and Viral Pat

  2026-05-25

  Angiotensin 1/2 (1-6)—the Asp-Arg-Val-Tyr-Ile-His hexapeptide—has emerged as a pivotal tool for dissecting renin-angiotensin system (RAS) signaling. This article synthesizes mechanistic insights and translational opportunities for researchers exploring vascular tone, renal dynamics, and the novel role of angiotensin fragments in viral pathophysiology, with a focus on SARS-CoV-2 spike–AXL binding. Strategic workflow guidance and protocol parameters are provided to accelerate robust, reproducible discoveries using APExBIO’s Angiotensin 1/2 (1-6).

• TP53-Dependent DHODH Inhibition in Nasopharyngeal Carcinoma

  2026-05-24

  Dong et al. demonstrate that inhibiting DHODH, a key enzyme in de novo pyrimidine synthesis, impairs nasopharyngeal carcinoma cell growth through TP53-dependent mechanisms. These findings highlight nucleic acid metabolism as a critical vulnerability in NPC and support DHODH inhibition as a promising therapeutic approach.

• Ferrostatin-1 (Fer-1): Reliable Ferroptosis Inhibition in Ce

  2026-05-23

  This article addresses practical laboratory challenges in cell viability, cytotoxicity, and ferroptosis assays while highlighting how Ferrostatin-1 (Fer-1), SKU A4371, from APExBIO, offers reproducible, data-backed solutions. Scenario-driven Q&A explores assay design, data interpretation, protocol optimization, and vendor reliability for biomedical researchers.

• Chloramphenicol in the Era of Plasmid-Mediated Multidrug Res

  2026-05-22

  Explore how chloramphenicol, a potent bacterial protein synthesis inhibitor, is redefining molecular biology research amidst the rise of plasmid-borne resistance. This article delivers new perspectives on protocol precision, resistance gene dynamics, and advanced assay design.

• Proteinase K: Mechanistic Mastery for Translational DNA Puri

  2026-05-22

  This article provides translational researchers with a mechanistic and strategic guide to leveraging Proteinase K, a recombinant broad-spectrum serine protease, for optimal DNA integrity and workflow reproducibility. Integrating findings from recent selectivity studies, competitive benchmarking, and protocol best practices, it demonstrates how APExBIO's Proteinase K (K1037) advances genomic DNA isolation and contaminant removal beyond standard methods.

• Merbromin Selectively Inhibits SARS-CoV-2 3CLpro Activity

  2026-05-21

  This study identifies Merbromin as a potent, mixed-type inhibitor of SARS-CoV-2's 3-chymotrypsin-like protease (3CLpro), providing mechanistic insight into its selectivity and binding. These findings lay the groundwork for targeted antiviral drug design without compromising essential protein hydrolysis enzymes like Proteinase K.

• Precision S-Phase Detection: Elevating Endothelial Research

  2026-05-21

  This thought-leadership article explores how mechanistic insights into endothelial dysfunction and vascular remodeling—exemplified by recent EGLN3 research—are reshaping translational research strategies. By integrating cutting-edge S-phase detection tools, such as EdU Imaging Kits (Cy5), and leveraging advances in click chemistry, researchers can now achieve unprecedented specificity and workflow efficiency in quantifying cell proliferation. The discussion bridges fundamental biology, competitive assay selection, and translational impact, offering actionable guidance for maximizing data fidelity and clinical relevance in contexts such as pulmonary hypertension and genotoxicity assessment.

• KR-12 Peptide: Antimicrobial and Antibiofilm Action Against

  2026-05-20

  This article reviews the pivotal study demonstrating that KR-12, a minimal fragment of the human antimicrobial peptide LL-37, retains potent antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. The findings highlight KR-12’s potential as a research tool in the development of alternative therapeutics targeting resistant pathogens and biofilm-associated infections.

• Cyanine 5-dCTP: Advancing Precision in Enzymatic DNA Synthes

  2026-05-20

  Explore how Cyanine 5-dCTP enables high-fidelity, red-fluorescent DNA labeling for advanced enzymatic oligonucleotide synthesis and detection. This article reveals the latest scientific insights and practical assay strategies that distinguish Cy5-dCTP from conventional fluorescent nucleotides.

695 records 12/47 page Previous Next First page 上5页 1112131415 下5页 Last page